✦ LIBER ✦

Gemcitabine plus docetaxel administered every other week as first-line treatment of metastatic breast cancer: Preliminary results from a phase II trial

✍ Scribed by Amadeu Pelegrı́; Lourdes Calvo; José I Mayordomo; Jesús Florián; Santiago Vázquez; Angels Arcusa; Marta Martı́n-Richard; José L Bayo; Javier Virizuela; Eva Carrasco; Antonio Antón

Book ID: 114473522
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 81 KB
Volume: 31
Category: Article
ISSN: 0093-7754
DOI: 10.1053/j.seminoncol.2004.03.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel/Gemcitabine Administered Every

Docetaxel/Gemcitabine Administered Every Other Week as First-Line Treatment for Metastatic Breast Cancer: Final Results of a Phase II Trial

✍ Amadeu Pelegrí; Lourdes Calvo; Antonio Antón; José I. Mayordomo; Jesús Florián; 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 107 KB

Capecitabine plus docetaxel every 3 week

Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial

✍ Lorenzen, S; Duyster, J; Lersch, C; von Delius, S; Hennig, M; Bredenkamp, R; Pes 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB

Multicentric phase II trial of gemcitabi

Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer

✍ Cappuzzo, F; Mazzoni, F; Gennari, A; Donati, S; Salvadori, B; Orlandini, C; Cett 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 90 KB

466 PUBLICATION A phase II trial of gemc

466 PUBLICATION A phase II trial of gemcitabine (G) and doxorubicin (D) combination as first line treatment of metastatic breast cancer: preliminary results

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 136 KB

A multicenter phase II trial of docetaxe

A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer

✍ N. Karachaliou; Ch. Kouroussis; P. Papakotoulas; K. Kalbakis; K. Tryfonidis; N. 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 194 KB

Phase II Trial of Weekly Docetaxel/Gemci

Phase II Trial of Weekly Docetaxel/Gemcitabine as First-Line Chemotherapy in Patients with Locally Recurrent or Metastatic Breast Cancer

✍ Joyce A. O'Shaughnessy; Robert Pluenneke; Jack Sternberg; Pankaj Khandelwal; Des 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 482 KB